GENERAL INFORMATION
Egyptian Journal Of Ophthalmology— EJO, published in 2021, is a global ophthalmological scientific publication and a peer-reviewed, open-access periodical published online 4 times per year (ISSN:2735-5012 online) (P.ISSN: 2735-4644). EJO is sponsored by Mansoura Ophthalmic Center (MOC), Faculty of Medicine, Mansoura University. MOC is an educational, research, and community institution that aims to achieve distinction and leadership in the field of medical research, education, and community service locally and nationally and one of the authorized training centers for the fellowship of the International Council of Ophthalmology (ICO) and Arabic board. EJO is registered and supported by the Egyptian
Knowledge Bank (EKB).
Aim & Scope
EJO is a comprehensive journal on ophthalmology accepting contributions in English from all over the world. These contributions mainly include original and review articles, both basic and clinical scientific manuscript. EJO applies itself to establish a leading ophthalmology journal in the world, to provide a platform for ophthalmologists, and impulse the advanced development of ophthalmology.
Manuscript Types
Original Articles (Basic Research and Clinical Research), Review, Meta-Analysis, Commentary, Investigation, Perspective, Opinion, Brief Report, and Letter to the Editor, etc.
Note: Submissions must be original contributions not previously published must not currently be under consideration for publication elsewhere in a similar form, in any language, including both paper and electronic formats.
EDITORIAL POLICIES
Peer Review
All manuscripts are subjected to double-blind peer review and editorial approval before accepting for publication. All contributions will be sent to at least two or more independent reviewers, selected by the editors. Authors are welcome to suggest suitable independent reviewers and may also request that the journal excludes one or two individuals or laboratories, but the editor's decision on the choice of referees is final. Editors, authors, and reviewers are required to keep confidential all details of the editorial and peer review process on submitted manuscripts, the peer review process is confidential and conducted anonymously; Outcomes of the review process include acceptance, acceptance with revisions but without re-review, revise and resubmit, or rejection. Results of the review process are normally available in about 1-2 months of submission.
Ethical Approval of Studies and Informed Consent
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki. Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants
All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. . Experimental research performed on animals must comply with the NIH Guide for the Care and Use of Laboratory Animals or equivalent. A statement that research has been performed according to the NIH Guidelines must be included in the Methods section.
Conflicts of Interest: A conflict of interest may exist when an author (or the author's institution or employer) has financial, or personal relationships that could inappropriately influence (or bias) the author's decisions, work, or manuscript. All authors are required to disclose potential conflicts of interest in the Acknowledgments section of the manuscript by following the Recommendations of the International Committee of Medical Journal Editors (ICMJE) http://www.icmje.org/urm_main.html
Authors without conflicts of interest, including relevant financial interests, activities, relationships, and affiliations, should indicate that no conflicts of interest exist in the Acknowledgments section of their manuscript.
e.g. Conflicts of Interest: Abou Samra W, None; Mokbel T, None; Azmy E, None; Hagras S, None.
Foundations: All financial support for the research and the work should be clearly and completely identified in an Acknowledgment section of the manuscript.
Clinical Trial Registry: When publishing clinical studies, EJO aims to comply with the Recommendations of the International Committee of Medical Journal Editors (ICMJE) on trials registration. Therefore, authors are requested to register the clinical trial presented in the manuscript in a public trials registry, and include the trial registration number in the Methods Section.
The following sites are recognized primary registries by the World Health Organization and the ICMJE.
http://www.anzctr.org.au/ (Australia)
http://www.chictr.org/ (China)
http://www.clinicaltrials.gov (US)
https://www.clinicaltrialsregister.eu (EU)
http://ctri.nic.in (India)
http://www.germanctr.de (Germany)
http://www.ensaiosclinicos.gov.br (Brazil)
http://www.irct.ir (Iran)
http://isrctn.org (UK)
http://ncrc.cdc.go.kr (Republic of Korea)
http://registroclinico.sld.cu (Cuba)
http://www.umin.ac.jp/ctr/index/htm (Japan)
http://www.trialregister.nl/trialreg/index.asp (the Netherlands)
Plagiarism
EJO uses Crossref Similarity Check (powered by iThenticate or Turnitin) to screen submitted contents, and we will do some investigation if the software raises any concerns. If plagiarism is detected after a manuscript is submitted, the manuscript will be rejected; If plagiarism is detected after publication, we may issue a correction or retraction notice for the related paper. We reserve the right to inform authors' institutions about plagiarism detected either before or after publication. Articles containing plagiarism will be removed from publication and will be reported to the proper authorities.
MANUSCRIPT PREPARATION REQUIREMENTS
Manuscripts are received with the explicit understanding that they are not under simultaneous consideration by any other publication, except in abstract form. Submission of an article for publication implies the transfer of the copyright from the author to the publisher upon acceptance.
Language Polishing: If an author's manuscript requires a language polishing service (excluding translation & rewrite), they can use the services from the Charlesworth group http://www.charlesworthauthorservices.com/?rcode=IJO001
Or SAGE language services https://languageservices.sagepub.com/en/
Cover Letter: Manuscripts must be accompanied by a cover letter. The authors must clearly explain the contribution of the work in terms of its theoretical and/or practical value, and association with previously published papers. The cover letter should also include a detailed contact address, and the email addresses for the first author, and the corresponding author.
The main manuscript document should be organized as follows:
Title Page: It is the first page of your manuscript, in which you must indicate the full manuscript title (≤12 notional words), the running title (≤6 notional words), the name(s) of the author(s), affiliation(s), institution(s) and/or department(s) where the work was accomplished, author contributions. In addition, the corresponding author’s name, full address with postal code, telephone and fax numbers, and email address must be included. Titles should be concise and informative (removing all unnecessary words), emphasize what is new, and avoid abbreviations. The name(s) of the author(s)' name(s) must be listed in the following manner: initial and/or first name, middle name or initial(s), and full family name.
Abstract: An informative, structured abstract of no more than 400 words should accompany each manuscript. Abstracts for original contributions should be structured into the following sections:
AIM: Only the purpose should be included.
METHODS: The materials, techniques, instruments, equipment and study designs, outcome measurements, and the experimental procedures as well as statistical methods should be included.
RESULTS: The observed and experimental results, including data, effects, outcomes, etc. should be included. The results should be concise and statistical significance should be presented as appropriate.
CONCLUSION: Conclusion should be justified by the study findings and the value of the findings should be specific in relation to its application.
Review articles require non-structured abstract.
KEYWORDS: Please list 3 to 8 keywords, selected mainly from Index Medicus, which reflect the content of the study.
Text: For original articles on either clinical science or laboratory science, the main text should be structured into the following sections: INTRODUCTION, SUBJECTS AND METHODS, RESULTS and DISCUSSION, and should include appropriate Figures and Tables. Data should be presented in the body text or in Figures and Tables, but not in both.
All submissions must be typed in Times New Roman with 12 pt, 1 spaced front, and 2cm margins all around. In a brief introduction, provide the research rationale, and objectives without extensively reviewing the literature. In the Methods section, describe the experimental design, subjects used, and procedures followed; provide sufficient details to enable others to duplicate the research. Use standard chemical or pharmaceutical terms. Make sure the metric unit and punctuation are used correctly. Please state clearly the statistics version and statistical method, and use the statistical symbols correctly. In parentheses, identify specific sources by the name of the company, city, or state of the country. Present the Results with a minimum of discussion. Cite all tables, and figures in numerical order. Limit the Discussion to statistically significant data and their limitations. Do not reiterate results.
Words: max 4000 (excluding figures and tables)
Figures/Tables: max 6
References: max 50
Reviews
Reviews should be on topics that are deemed to be relevant to the audience of the Journal. Containing the current state of knowledge or practice, integrating recent advances with accepted principles and practice, or summarizing and analyzing consensus view of controversial issues in the knowledge of the practice. A non-structured abstract is required.
Surgical techniques
Previously unpublished short manuscripts describing new operative procedures or improvements in existing procedures or describing innovative surgical techniques. Each manuscript should be divided as follows: Introduction, Methods, Results, and Conclusions. If possible, include a video demonstrating the technique described, which will be published as online-only supplementary material. A structured abstract is required.
Words: max 3000 (excluding figures and tables)
Figures/Tables: max 5
References: max 20
Case reports
Case reports will be accepted if they describe a previously undescribed clinical case and are of very high importance for dissemination. Case reports will be published online only. Case reports must be structured as follows: Introduction (explaining the importance of the case), Case Description (providing all relevant information), and Conclusions (describing the detailed outcome of the report). A structured abstract is required.
Words: max 2000 (excluding figures and tables)
Figures/Tables: max 3
References: max 10
Authorship
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
Acknowledgments: The Acknowledgements section is the general term that includes the list of contributions, disclosures, credits, and other information included at the end of the text of a manuscript but before the references. The Acknowledgements section includes authors' contributions; information on author access to data; disclosure of potential conflicts of interest, including financial interests, activities, relationships, and affiliations; sources of funding and support; an explanation of the role of sponsor(s)
All other persons who have made substantial contributions to the work reported in this manuscript (e.g. data collection, analysis, and writing or editing assistance), but who do not fulfill the authorship criteria should be named with their specific contributions in an Acknowledgements in the manuscript.
Authors must obtain written permission to include the names of all individuals included in the Acknowledgements section, and the corresponding author must confirm that such permission.
References: Authors should cite the literature published in recent 5 years as many as possible, while over past 10 years as few as possible. The Price Index (number of literature published in recent 5 years/total number of references×100) should be over 30%. List references numerically by order of citation in the text, not alphabetically. All references must be cited in the text or tables, shown as superscript numbers. Authors are responsible for the accuracy of references. References should follow the standards summarized in the recommendations of ICMJE http://www.icmje.org/urm_main.html.
Journals
Authors' surnames and initials. Article title. Abbreviated name of journal Year; vol (issue No.): inclusive pages.
e.g. :
Abou Samra W, Mokbel T, Elwan M, Saleh S, Elwehidy A, Iqbal M, Ellayeh A. Two-stage procedure in the management of selected cases of keratoconus: clear lens extraction with aspherical IOL implantation followed by WFG-PRK. Int J Ophthalmol 2018;11(11):1761-1767
Elhefney E,Mokbel T,Samra WA,Kishk H,Mohsen T,El-Kannishy A.Long-term results of Ahmed glaucoma valve implantation in Egyptian population. Int J Ophthalmol 2018;11(3):416-421
Books
1 An entire book: Authors' surnames and initials. Book Title. Edition number (if it is the second edition or above). State (or Country) of publisher: Publisher's name; copyright year.
e.g. Naumann GOH, Holbach L, Kruse FE. Applied Pathology for Ophthalmic Microsurgeons. Germany: Springer; 2008; p 30.
2 Chapter in a book: Authors' surnames and initials. Chapter Title. Surname and initials of book authors or editors (or translator, if any). Book Title. Edition number (if it is the second edition or above). State (or Country) of publisher: Publisher's name; copyright year. Page number.
e.g. Bye L, Modi N, Stanford M. Anatomy. In Basic Sciences for Ophthalmology. UK: Oxford University Press; 2013; pp 1:1-10.
Figure Legends and Figures: Figures should be embedded in the main text where the figures are applicable and also should be uploaded as separate files to the online submission system. Figures should be numbered as 1, 2, 3 and so on, and mentioned clearly in the main text. For photomicrographs, include the type of specimen, original magnification or a scale bar, and stain. For gross pathology specimens, label any rulers with unit of measure. Digitally enhanced images (CT/MRI, blots, photographs, photomicrographs, ultrasound images, x-ray films, etc.) must be clearly identified in the figure legends as digitally processed images.
Individual figure files - must be TIFF (.tif), or JPG (.jpg) files.
Tables: Tables should be in Word format and placed in the main text where the table is first cited, which should not use picture tools to create tables or upload tables in image format or in Excel files. Tables must be cited in the main text in numerical order. A table need to be simplified when it cannot fit onto one page. Tables should be self-explanatory and the data they contain must not be duplicated in the text or figures. Each table should have a brief title and all abbreviations within the table should be included in a footnote to the table. Each piece of data needs to be contained in its own cell and the boxhead should not be empty.
MANUSCRIPT SUBMISSION REQUIREMENTS
All manuscripts must be submitted via our online manuscript submission and review system (https://ejomos.journals.ekb.eg).
Manuscript Components: Include in the manuscript file a title page, abstract, text, acknowledgments, references, and figure legends. Beginning with the title page, start each of these sections on a new page, and number them consecutively.
Recommended File Sizes: We recommend individual file sizes of no more than 500KB, and not exceeding 1MB, with the total size for all files not exceeding 10MB (not including any video files).
Manuscript File Formats: For submission and review, the acceptable manuscript file format is Microsoft Word. Do not submit your manuscript in PDF format.
COPYRIGHT
Once the manuscript is adopted by EJO, a Copyright Transfer Agreement signed by all the authors should be submitted immediately.
Publication Policy
Only manuscripts of sufficient quality that meet the aims and scope of the Egyptian Journal of Ophthalmology will be reviewed.
There are no fees payable to submit or publish in this journal.
Open Access statement
All of the articles are free to access immediately on EJO Press website from the date of publication.
Contact us
Egyptian Journal of Ophthalmology Press (EJO Press)
Mansoura Ophthalmic Center, Mansoura University, ElGomhoriah street, Mansoura, Egypt (35516)
Tel: (+20 50 2202064) Fax: (+20 502203043 )
Email: ejo_moc@yahoo.com
Website: https://ejomos.journals.ekb.eg